- Assistant Professor, CWRU School of Medicine
Rachel Weinerman, MD joined university hospitals in 2015 and has been the Program Director since 2021. Dr. Weinerman is a physician-scientist with an interest in the effects of clinical manipulations used in assisted reproductive technologies on neonatal outcomes. Her work in this area has earned national attention as she was the recipient of the ASRM Prize Paper award in 2015 as well as the 2019 SREI research grant. Dr. Weinerman serves as a primary research mentor for the fellows and previous fellows have had significant success in our reproductive biology and mouse ART lab, with a track record of successful grant funding and high-quality publications during their fellowships. Dr. Weinerman is also a nationally-recognized educator in the field of REI and enjoys teaching fellows in the clinic and during the Tuesday didactic sessions, where fellows explore reproductive physiology in-depth.
- Fertility Preservation
- In Vitro Fertilization
- Intrauterine Insemination
- Menstrual Cycle Issues
- Minimally Invasive Surgery
- Ovulation Induction
- Polycystic Ovary Syndrome (PCOS)
- Recurrent Pregnancy Loss
- Reproductive Endocrinology and Infertility
- Same-Sex Couples
2015 Luigi Mastroianni Research Award, Philadelphia Area Reproductive Endocrine Society
2015 Society for Reproductive Endocrinology Prize Paper Award, American Society for Reproductive Medicine Annual Meeting, Baltimore, MD
2014 Research grant from the Foundation for the Assessment and Enhancement of Embryonic Competence
2014 Society of Reproductive Biologists Award for oral presentation at the American Society for Reproductive Medicine Annual Meeting, Honolulu, HI
2013 National Research Service Institutional Training Award (T32), University of Pennsylvania
Patient Experience Reviews
4.9 out of 5
Patient Comments (6)
Reviewed On 4/1/2022
Dr. Weinerman's patience and concerns for me were sincere. She explained everything so clearly, answered all my questions and was reassuring to me. She has excellent bedside manner and is such a nice person. She is an excellent doctor, it is obvious that she knows her field of expertise inside out.
Reviewed On 3/1/2022
She is generally very good. Sometimes her recommendation are fluid and I wish I could get a more solid answer from her. It's a lot of here are two options I'm ok with either one. I would like for her to be able to say here are two options and which one she recommends most. Also her staff at Crocker is amazing. I wish everything could be done at that office. ***
Reviewed On 1/1/2022
She was kind, but straight forward. She told me exactly what I should expect. ***
Reviewed On 10/1/2021
Provider is very compassionate and knowledgeable. She takes the time to explain everything in detail so I can understand, and she also presents multiple options for my care and helps me weigh pros and cons of each so I can make the best decision for me. Excellent personalized health care!
Reviewed On 10/1/2021
Dr. Weinerman is very caring and compassionate, and she always fully explains all my options. I have the utmost trust in her for my medical care.
Reviewed On 9/1/2021
Great care from Dr. Weinerman and most of her team. ***
- Reproductive Endocrinology/Infertility - American Board of Obstetrics and Gynecology
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Fellowship | Reproductive Endocrinology
Reproductive Endocrinology - University Of Pennsylvania School Of Medicine (2012 - 2015)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - New York University School Of Medicine And Langone Medical Center (2008 - 2012)
Harvard Medical School (2008)
Harvard University (2003)
In-vitro fertilization perinatal outcomes, Embryo selection, Embryo vitrification
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Rachel Weinerman did not disclose any Outside Relationships with Industry.